Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

OTHER 2NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Neoplasm Metastasis 1Colorectal Neoplasms 1Carcinoma 1Breast Neoplasms 1Adenocarcinoma 1

Interventions

Docetaxel 3regorafenib 2Doxorubicin 2trifluridine tipiracil drug combination 1pegfilgrastim 1enzalutamide 1darolutamide 1bicalutamide 1apalutamide 1abiraterone 1Triptorelin Pamoate 1Trifluridine 1Surgical Procedures, Operative 1Pancreaticoduodenectomy 1Paclitaxel 1Nivolumab 1Irinotecan 1Cyclophosphamide 1Cisplatin 1CP protocol 1Bevacizumab 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Adenocarcinoma × trifluridine tipiracil drug combination × Clear all
NCT04879368 2025-07-17

INTEGRATEIIb

Australasian Gastro-Intestinal Trials Group

Phase 3 Active not recruiting
450 enrolled
Tumor-Agnostic

Adenocarcinoma, Carcinoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡